Skip to main content
NCBI home page
Gut logoLink to Gut
. 2002 May;50(Suppl 3):iii60–iii64. doi: 10.1136/gut.50.suppl_3.iii60

Immunoregulation in the gut: success and failures in human disease

I Monteleone, P Vavassori, L Biancone, G Monteleone, F Pallone
PMCID: PMC1867679  PMID: 11953335

Full Text

The Full Text of this article is available as a PDF (130.7 KB).

Figure 1 .

Figure 1

Open in a new tab

CD4+ T cell subsets and their products in the human intestinal mucosa.

Figure 2 .

Figure 2

Open in a new tab

CD4+ T cell subsets in human intestinal mucosa. During uncontrolled inflammation the number of CD4+ effector T cells is increased while the proportion of CD4+ regulatory T cells tend to remain relatively stable.

Figure 3 .

Figure 3

Open in a new tab

IL-15 enhances T-LPL cell resistance to apoptosis by stimulating the release of Bcl-2.

Figure 4 .

Figure 4

Open in a new tab

Driving a Th1 response in Crohn's disease.

Figure 5 .

Figure 5

Open in a new tab

Th1 and Th2 profiles in inflammatory bowel disease: a dogma to be disputed.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature. 1996 Oct 31;383(6603):787–793. doi: 10.1038/383787a0. [DOI] [PubMed] [Google Scholar]
  2. Atreya R., Mudter J., Finotto S., Müllberg J., Jostock T., Wirtz S., Schütz M., Bartsch B., Holtmann M., Becker C. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med. 2000 May;6(5):583–588. doi: 10.1038/75068. [DOI] [PubMed] [Google Scholar]
  3. Bajaj-Elliott M., Poulsom R., Pender S. L., Wathen N. C., MacDonald T. T. Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest. 1998 Oct 15;102(8):1473–1480. doi: 10.1172/JCI2792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boirivant M., Marini M., Di Felice G., Pronio A. M., Montesani C., Tersigni R., Strober W. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology. 1999 Mar;116(3):557–565. doi: 10.1016/s0016-5085(99)70177-0. [DOI] [PubMed] [Google Scholar]
  5. Boirivant M., Pica R., DeMaria R., Testi R., Pallone F., Strober W. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest. 1996 Dec 1;98(11):2616–2622. doi: 10.1172/JCI119082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cario E., Podolsky D. K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000 Dec;68(12):7010–7017. doi: 10.1128/iai.68.12.7010-7017.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chikano S., Sawada K., Shimoyama T., Kashiwamura S. I., Sugihara A., Sekikawa K., Terada N., Nakanishi K., Okamura H. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut. 2000 Dec;47(6):779–786. doi: 10.1136/gut.47.6.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Das K. M., Dasgupta A., Mandal A., Geng X. Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis. J Immunol. 1993 Mar 15;150(6):2487–2493. [PubMed] [Google Scholar]
  9. Das K. M., Vecchi M., Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology. 1990 Feb;98(2):464–469. doi: 10.1016/0016-5085(90)90839-s. [DOI] [PubMed] [Google Scholar]
  10. De Maria R., Boirivant M., Cifone M. G., Roncaioli P., Hahne M., Tschopp J., Pallone F., Santoni A., Testi R. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest. 1996 Jan 15;97(2):316–322. doi: 10.1172/JCI118418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Duerr R. H., Targan S. R., Landers C. J., LaRusso N. F., Lindsay K. L., Wiesner R. H., Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991 May;100(5 Pt 1):1385–1391. [PubMed] [Google Scholar]
  12. Fais S., Capobianchi M. R., Pallone F., Di Marco P., Boirivant M., Dianzani F., Torsoli A. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. Gut. 1991 Apr;32(4):403–407. doi: 10.1136/gut.32.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Farstad I. N., Halstensen T. S., Lien B., Kilshaw P. J., Lazarovits A. I., Brandtzaeg P., Lazarovitz A. I. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology. 1996 Oct;89(2):227–237. doi: 10.1046/j.1365-2567.1996.d01-727.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998 Jul;115(1):182–205. doi: 10.1016/s0016-5085(98)70381-6. [DOI] [PubMed] [Google Scholar]
  15. Fuss I. J., Marth T., Neurath M. F., Pearlstein G. R., Jain A., Strober W. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology. 1999 Nov;117(5):1078–1088. doi: 10.1016/s0016-5085(99)70392-6. [DOI] [PubMed] [Google Scholar]
  16. Fuss I. J., Neurath M., Boirivant M., Klein J. S., de la Motte C., Strong S. A., Fiocchi C., Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996 Aug 1;157(3):1261–1270. [PubMed] [Google Scholar]
  17. Halstensen T. S., Das K. M., Brandtzaeg P. Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut. 1993 May;34(5):650–657. doi: 10.1136/gut.34.5.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Heuschkel R. B., MacDonald T. T., Monteleone G., Bajaj-Elliott M., Smith J. A., Pender S. L. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut. 2000 Jul;47(1):57–62. doi: 10.1136/gut.47.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ina K., Itoh J., Fukushima K., Kusugami K., Yamaguchi T., Kyokane K., Imada A., Binion D. G., Musso A., West G. A. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol. 1999 Jul 15;163(2):1081–1090. [PubMed] [Google Scholar]
  20. Kanai T., Watanabe M., Okazawa A., Nakamaru K., Okamoto M., Naganuma M., Ishii H., Ikeda M., Kurimoto M., Hibi T. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology. 2000 Dec;119(6):1514–1523. doi: 10.1053/gast.2000.20260. [DOI] [PubMed] [Google Scholar]
  21. Keates A. C., Castagliuolo I., Cruickshank W. W., Qiu B., Arseneau K. O., Brazer W., Kelly C. P. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology. 2000 Oct;119(4):972–982. doi: 10.1053/gast.2000.18164. [DOI] [PubMed] [Google Scholar]
  22. Kett K., Rognum T. O., Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology. 1987 Nov;93(5):919–924. doi: 10.1016/0016-5085(87)90552-x. [DOI] [PubMed] [Google Scholar]
  23. Kitani A., Fuss I. J., Nakamura K., Schwartz O. M., Usui T., Strober W. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med. 2000 Jul 3;192(1):41–52. doi: 10.1084/jem.192.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liu Z., Geboes K., Colpaert S., D'Haens G. R., Rutgeerts P., Ceuppens J. L. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol. 2000 Apr 1;164(7):3608–3615. doi: 10.4049/jimmunol.164.7.3608. [DOI] [PubMed] [Google Scholar]
  25. Louis E., Ribbens C., Godon A., Franchimont D., De Groote D., Hardy N., Boniver J., Belaiche J., Malaise M. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol. 2000 May;120(2):241–246. doi: 10.1046/j.1365-2249.2000.01227.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. MacDonald T. T., Bajaj-Elliott M., Pender S. L. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today. 1999 Nov;20(11):505–510. doi: 10.1016/s0167-5699(99)01536-4. [DOI] [PubMed] [Google Scholar]
  27. MacDonald T. T., Monteleone G., Pender S. L. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol. 2000 Jan;51(1):2–9. doi: 10.1046/j.1365-3083.2000.00658.x. [DOI] [PubMed] [Google Scholar]
  28. MacDonald T. T., Pender S. L. Lamina propria T cells. Chem Immunol. 1998;71:103–117. doi: 10.1159/000058721. [DOI] [PubMed] [Google Scholar]
  29. MacDonald T. T. T cell immunity to oral allergens. Curr Opin Immunol. 1998 Dec;10(6):620–627. doi: 10.1016/s0952-7915(98)80079-4. [DOI] [PubMed] [Google Scholar]
  30. Monteleone G., Biancone L., Marasco R., Morrone G., Marasco O., Luzza F., Pallone F. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology. 1997 Apr;112(4):1169–1178. doi: 10.1016/s0016-5085(97)70128-8. [DOI] [PubMed] [Google Scholar]
  31. Monteleone G., Kumberova A., Croft N. M., McKenzie C., Steer H. W., MacDonald T. T. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest. 2001 Aug;108(4):601–609. doi: 10.1172/JCI12821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Monteleone G., MacDonald T. T., Wathen N. C., Pallone F., Pender S. L. Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology. 1999 Nov;117(5):1069–1077. doi: 10.1016/s0016-5085(99)70391-4. [DOI] [PubMed] [Google Scholar]
  33. Monteleone G., Parrello T., Luzza F., Pallone F. Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7. Gut. 1998 Nov;43(5):620–628. doi: 10.1136/gut.43.5.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Monteleone G., Trapasso F., Parrello T., Biancone L., Stella A., Iuliano R., Luzza F., Fusco A., Pallone F. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol. 1999 Jul 1;163(1):143–147. [PubMed] [Google Scholar]
  35. Nagata S., McKenzie C., Pender S. L., Bajaj-Elliott M., Fairclough P. D., Walker-Smith J. A., Monteleone G., MacDonald T. T. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol. 2000 Nov 1;165(9):5315–5321. doi: 10.4049/jimmunol.165.9.5315. [DOI] [PubMed] [Google Scholar]
  36. Neurath M. F., Becker C., Barbulescu K. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut. 1998 Dec;43(6):856–860. doi: 10.1136/gut.43.6.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Neurath M. F., Fuss I., Kelsall B. L., Stüber E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995 Nov 1;182(5):1281–1290. doi: 10.1084/jem.182.5.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Onuma E. K., Amenta P. S., Ramaswamy K., Lin J. J., Das K. M. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5. Clin Exp Immunol. 2000 Sep;121(3):466–471. doi: 10.1046/j.1365-2249.2000.01330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pallone F., Fais S., Squarcia O., Biancone L., Pozzilli P., Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut. 1987 Jun;28(6):745–753. doi: 10.1136/gut.28.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pallone F., Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut. 1998 Dec;43(6):735–736. doi: 10.1136/gut.43.6.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Parrello T., Monteleone G., Cucchiara S., Monteleone I., Sebkova L., Doldo P., Luzza F., Pallone F. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol. 2000 Dec 15;165(12):7234–7239. doi: 10.4049/jimmunol.165.12.7234. [DOI] [PubMed] [Google Scholar]
  42. Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., Maggi E., Pupilli C., Tonelli F., Romagnani S. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 1997 Mar;150(3):823–832. [PMC free article] [PubMed] [Google Scholar]
  43. Pender S. L., Fell J. M., Chamow S. M., Ashkenazi A., MacDonald T. T. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol. 1998 Apr 15;160(8):4098–4103. [PubMed] [Google Scholar]
  44. Pender S. L., Tickle S. P., Docherty A. J., Howie D., Wathen N. C., MacDonald T. T. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol. 1997 Feb 15;158(4):1582–1590. [PubMed] [Google Scholar]
  45. Pospai D., René E., Fiasse R., Farahat K., Beaugery L., Lammens P., Reimund C., Duclos B., Le Quintrec Y., Vandercam B. Crohn's disease stable remission after human immunodeficiency virus infection. Dig Dis Sci. 1998 Feb;43(2):412–419. doi: 10.1023/a:1018883112012. [DOI] [PubMed] [Google Scholar]
  46. Saarialho-Kere U. K., Vaalamo M., Puolakkainen P., Airola K., Parks W. C., Karjalainen-Lindsberg M. L. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol. 1996 Feb;148(2):519–526. [PMC free article] [PubMed] [Google Scholar]
  47. Sido B., Braunstein J., Breitkreutz R., Herfarth C., Meuer S. C. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med. 2000 Sep 18;192(6):907–912. doi: 10.1084/jem.192.6.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Simpson S. J., Shah S., Comiskey M., de Jong Y. P., Wang B., Mizoguchi E., Bhan A. K., Terhorst C. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med. 1998 Apr 20;187(8):1225–1234. doi: 10.1084/jem.187.8.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000 Aug 25;289(5483):1352–1355. doi: 10.1126/science.289.5483.1352. [DOI] [PubMed] [Google Scholar]
  50. Van Deventer S. J. Tumour necrosis factor and Crohn's disease. Gut. 1997 Apr;40(4):443–448. doi: 10.1136/gut.40.4.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Weiner H. L., Friedman A., Miller A., Khoury S. J., al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–837. doi: 10.1146/annurev.iy.12.040194.004113. [DOI] [PubMed] [Google Scholar]
  52. Wirtz S., Finotto S., Kanzler S., Lohse A. W., Blessing M., Lehr H. A., Galle P. R., Neurath M. F. Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. J Immunol. 1999 Feb 15;162(4):1884–1888. [PubMed] [Google Scholar]
  53. Yamamoto M., Yoshizaki K., Kishimoto T., Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol. 2000 May 1;164(9):4878–4882. doi: 10.4049/jimmunol.164.9.4878. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES